Ototoxicity

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

A Comparison of Infection Rates Between Two Surgical Sites

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

Aminoglycoside Plasma Level Measurement in Neonates With Infection

Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors